These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31328452)

  • 1. Prognostic value of post-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis.
    Kim YJ; Han S; Kim YS; Nam JH
    J Gynecol Oncol; 2019 Sep; 30(5):e66. PubMed ID: 31328452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
    Dhull VS; Sharma P; Sharma DN; Maharjan S; Suman Kc S; Patel C; Bal C; Kumar R
    Int J Gynecol Cancer; 2014 Feb; 24(2):312-20. PubMed ID: 24407578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Volume-Based Metabolic Parameters of
    Han S; Kim H; Kim YJ; Suh CH; Woo S
    AJR Am J Roentgenol; 2018 Nov; 211(5):1112-1121. PubMed ID: 30207790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of
    Han S; Woo S; Kim YI; Yoon DH; Ryu JS
    Eur Radiol; 2021 Jan; 31(1):152-162. PubMed ID: 32809165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of
    Han S; Choi JY
    Breast Cancer Res; 2020 Oct; 22(1):119. PubMed ID: 33129348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
    Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):185-90. PubMed ID: 22014958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography or PET-computed tomography in cervical cancer: a meta-analysis.
    Zhao Q; Feng Y; Mao X; Qie M
    Int J Gynecol Cancer; 2013 Sep; 23(7):1184-90. PubMed ID: 23851677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of SUV
    Diao W; Tian F; Jia Z
    Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
    Sun Y; Lu P; Yu L
    Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography.
    Mckinnish TR; Greenwade MM; Wilkinson-Ryan I; Schwarz JK; Powell MA; Mutch DG; Massad LS; Grigsby PW; Siegel BA; Thaker PH
    Gynecol Oncol; 2022 Jul; 166(1):173-180. PubMed ID: 35537885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
    Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
    Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
    Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT
    Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy.
    Scarsbrook A; Vaidyanathan S; Chowdhury F; Swift S; Cooper R; Patel C
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):581-588. PubMed ID: 27738729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.
    Mac Manus MP; Hicks RJ; Matthews JP; Wirth A; Rischin D; Ball DL
    Lung Cancer; 2005 Jul; 49(1):95-108. PubMed ID: 15949595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.
    Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
    JAMA; 2007 Nov; 298(19):2289-95. PubMed ID: 18029833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
    Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.
    Day FL; Link E; Ngan S; Leong T; Moodie K; Lynch C; Michael M; Winton Ed; Hogg A; Hicks RJ; Heriot A
    Br J Cancer; 2011 Aug; 105(4):498-504. PubMed ID: 21792197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive values of interim
    Han S; Kim YI; Woo S; Kim TH; Ryu JS
    Ann Nucl Med; 2021 Apr; 35(4):447-457. PubMed ID: 33471289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis.
    Sadeghi R; Harsini S; Qodsi Rad MA; Dabbagh VR; Treglia G
    Contrast Media Mol Imaging; 2018; 2018():9760492. PubMed ID: 30627062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.